Zevenbergen Capital Investments LLC / SG7
Zevenbergen Capital Investments LLC’s Sage Therapeutics Inc Position
Does Zevenbergen Capital Investments LLC own Sage Therapeutics Inc (SG7)? Not currently — the last reported position was 236.6K shares worth $17M in Q4 2019; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$17M
Q4 2019
Shares
236.6K
% of Portfolio
+0.63%
Quarters Held
2
position exited
Position History SG7
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Zevenbergen Capital Investments LLC’s full portfolio or all institutional holders of SG7.